TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/24 17:00 | 6/3/24 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | S | -87 | 16.30 | 0 | -5 | -100 | 0 | D | |||||||||||||||
2/16/24 17:00 | 2/15/24 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | M.d | 0 | 0.00 | 0 | 4 | 300 | 5 | D | |||||||||||||||
12/29/23 17:00 | 12/27/23 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D | |||||||||||||||
12/19/23 17:00 | 12/15/23 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | S.d | -201 | 14.39 | 0 | -14 | -100 | 0 | D | |||||||||||||||
12/19/23 17:00 | 12/15/23 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | M.d | 58 | 5.78 | 0 | 10 | 0 | D | ||||||||||||||||
2/17/23 17:01 | 2/15/23 | CPRX | Catalyst Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harper Molly | FL | D | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |